Yirui Zhai

890 total citations
58 papers, 465 citations indexed

About

Yirui Zhai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yirui Zhai has authored 58 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yirui Zhai's work include Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (10 papers) and Lung Cancer Research Studies (10 papers). Yirui Zhai is often cited by papers focused on Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (10 papers) and Lung Cancer Research Studies (10 papers). Yirui Zhai collaborates with scholars based in China, United States and United Kingdom. Yirui Zhai's co-authors include Zhouguang Hui, Lühua Wang, Zongmei Zhou, Qinfu Feng, Jun Liang, Zefen Xiao, Nan Bi, Dongfu Chen, Hong‐Xing Zhang and Yousheng Mao and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Yirui Zhai

51 papers receiving 459 citations

Peers

Countries citing papers authored by Yirui Zhai

Since Specialization

Citations

This map shows the geographic impact of Yirui Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yirui Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yirui Zhai more than expected).

Fields of papers citing papers by Yirui Zhai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yirui Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yirui Zhai. The network helps show where Yirui Zhai may publish in the future.

Co-authorship network of co-authors of Yirui Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Yirui Zhai. A scholar is included among the top collaborators of Yirui Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yirui Zhai. Yirui Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Postoperative radiotherapy improves disease-free survival of EGFR wild-type pN2 non-squamous-cell non-small-cell lung cancer (Nsq-NSCLC) patients after complete resection: a propensity score matching analysis 2025 ·Radiation Oncology ·Yunsong Liu, Yu Men, Xu Yang, Shuang Sun, (unknown), (unknown), Yang Wang, Yirui Zhai, Jianyang Wang, Lei Deng, Wenqing Wang, Nan Bi, Lühua Wang, Zhouguang Hui	0
2	Can ADC changes help mRECIST or LI-RADS treatment response algorithm better diagnose pathological response of HCC after preoperative radiotherapy? Secondary analysis of a prospective phase 2 trial 2025 ·Insights into Imaging ·Rong Cong, Fan Wu, Yirui Zhai, Feng Ye, Shuang Wang, Zhaowei Chen, Bing Feng, Leyao Wang, Yongjian Zhu, Sicong Wang, Li Zhao, Bo Chen, Xiaohong Ma	0
3	Dosimetric benefit and clinical feasibility of deep inspiration breath-hold and volumetric modulated arc therapy-based postmastectomy radiotherapy for left-sided breast cancer 2024 ·Scientific Reports ·Shijia Wang, Yirui Zhai, Wen‐Wen Zhang, Siye Chen, (unknown), (unknown), Yu Tang, Yong-Wen Song, Yueping Liu, Bo Chen, Shunan Qi, (unknown), (unknown), Ye‐Xiong Li, Jing Hao, Shulian Wang	0
4	Optimizing the prognostic capacity of baseline 18F-FDG PET/CT metabolic parameters in extranodal natural killer/T-cell lymphoma by using relative and absolute thresholds 2024 ·Heliyon ·Yingming Zhu, (unknown), Xin Liu, Shu‐Nan Qi, Shulian Wang, Hui Fang, Yongwen Song, Yueping Liu, Jing Jin, Ning Li, Ning-Ning Lu, (unknown), Yuan Tang, Bo Chen, Wen‐Wen Zhang, Yirui Zhai, Yong Yang, Bin Liang, Rong Zheng, Ye‐Xiong Li	2
5	Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II study 2024 ·BMC Cancer ·Zhuoran Li, (unknown), (unknown), Yirui Zhai, Tao Zhang, Nan Bi, Jingbo Wang, Xin Wang, Wenyang Liu, Zefen Xiao, Dongfu Chen, (unknown), (unknown), Wenqing Wang, Zongmei Zhou	4
6	Radiotherapy with Targeted Therapy or Immune Checkpoint Inhibitors for Hepatocellular Carcinoma with Hepatic Vein and/or Inferior Vena Cava Tumor Thrombi 2024 ·Journal of Hepatocellular Carcinoma ·Zhuoran Li, Yirui Zhai, Fan Wu, Da‐Yong Cao, Feng Ye, Yan Song, Shulian Wang, (unknown), Yong-Wen Song, Yuan Tang, Jing Hao, Hui Fang, Shunan Qi, (unknown), Ye‐Xiong Li, Jianxiong Wu, (unknown)	2
7	Higher immune cell radiation dose is correlated with poor tumor control and survival in patients with non-small cell lung cancer receiving postoperative radiotherapy 2024 ·BMC Cancer ·(unknown), Yunsong Liu, (unknown), (unknown), Xu Yang, Yu Men, Jianyang Wang, Lei Deng, Yirui Zhai, Chen Hu, Nan Bi, Lühua Wang, Zhouguang Hui	1
8	Preoperative CT-based radiomic prognostic index to predict the benefit of postoperative radiotherapy in patients with non-small cell lung cancer: a multicenter study 2024 ·Cancer Imaging ·(unknown), Yu Men, Yunsong Liu, (unknown), (unknown), Xu Yang, Jianyang Wang, Lei Deng, Yirui Zhai, Nan Bi, Lühua Wang, Zhouguang Hui	3
9	Higher Lung and Heart Doses Decrease Early and Long-Term Survival, Respectively, in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation 2023 ·Advances in Radiation Oncology ·(unknown), Yunsong Liu, (unknown), Meng Yuan, Yang Xu, (unknown), Jianyang Wang, Lei Deng, Yirui Zhai, Nan Bi, Lühua Wang, Zhouguang Hui	8
10	Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial 2023 ·Thoracic Cancer ·(unknown), Bin Liang, (unknown), Yunsong Liu, (unknown), Meng Yuan, Yu Men, Jianyang Wang, Lei Deng, Yirui Zhai, Nan Bi, Lühua Wang, (unknown), Zhouguang Hui	8
11	Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy 2022 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Xin Liu, Yong Yang, Shulian Wang, Hui Fang, Yongwen Song, Yue‐Ping Liu, Jing Jin, Ning Li, Ning-Ning Lu, (unknown), Yuan Tang, Bo Chen, Wen‐Wen Zhang, Yirui Zhai, Kuo Men, Jianrong Dai, Min Deng, Shu‐Nan Qi, Ye‐Xiong Li	2
12	MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome 2022 ·Cancer Cell International ·Yu Men, Yirui Zhai, Lihong Wu, Lipin Liu, (unknown), Wei Jiang, Nan Bi, Yongmei Song, (unknown), Lühua Wang	9
13	Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment 2022 ·Frontiers in Oncology ·Meng Yuan, Yirui Zhai, Zhouguang Hui	4
14	Adenoid Cystic Carcinoma of Lobar Bronchial Origin: 20-Year Experience at a Single Institution 2022 ·Annals of Surgical Oncology ·(unknown), (unknown), Yirui Zhai, Zongmei Zhou, Nan Bi, Yousheng Mao, Yi Zhang, Zefen Xiao, Shugeng Gao, Jima Lv, Qi Xue, Qinfu Feng	8
15	Long-Term Outcome of Centrally Located Hepatocellular Carcinomas Treated by Radical Resection Combined With Intraoperative Electron Radiotherapy (IOERT) 2022 ·Frontiers in Oncology ·Yan‐Ling Wu, Yirui Zhai, Minghui Li, Jianqiang Cai, (unknown), Liming Wang, Xiuhong Wu, Xiaodan Wang, Fan Wu, Qiang Zeng, Bo Chen, Ye‐Xiong Li, Jianxiong Wu, Qinfu Feng	3
16	The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non-small cell lung cancer receiving chemoradiotherapy 2020 ·Journal of Thoracic Disease ·Tao Zhang, Nan Bi, Zongmei Zhou, Dongfu Chen, (unknown), Jun Liang, Zefen Xiao, Zhouguang Hui, Jima Lv, (unknown), Lei Deng, Wenqing Wang, Wenyang Liu, Jianyang Wang, Yirui Zhai, Lühua Wang	15
17	A Single-Center Analysis of the Treatment and Prognosis of Patients With Thymic Carcinoma 2017 ·The Annals of Thoracic Surgery ·Yirui Zhai, Zhouguang Hui, Wei Ji, Xiaozhen Wang, Jun Liang, Yousheng Mao, Yang Luo, Shuangmei Zou, Jima Lv, Zongmei Zhou, Dongfu Chen, Hong‐Xing Zhang, Zefen Xiao, Lühua Wang, Qinfu Feng	20
18	Continuous intravenous pumping (CIP) of recombinant human endostatin (Endostar) combined with concurrent radiochemotherapy in patients with unresectable stage III non-small-cell lung cancer: preliminary data of a prospective multicenter phaseIIclinical trial 2016 ·Zhonghua fangshe zhongliuxue zazhi ·(unknown), Zhouguang Hui, Lujun Zhao, Yujin Xu, Yirui Zhai, (unknown), (unknown), Guangying Zhu, Dongming Li, Yu Tang, Jun Liang, Yue Kong, Ming Chen, (unknown)	3
19	Analysis of treatment outcome for stage III thymoma 2012 ·Zhonghua fangshe zhongliuxue zazhi ·Chengcheng Fan, Qinfu Feng, Yirui Zhai, Hong‐Xing Zhang, Dongfu Chen, Zefen Xiao, Zongmei Zhou, Jun Liang, Jima Lv, Zhouguang Hui, (unknown)	1
20	Inhibition of STAT1 sensitizes renal cell carcinoma cells to radiotherapy and chemotherapy 2012 ·Cancer Biology & Therapy ·Hongxia Zhu, (unknown), Qing Xu, Ye Zhang, Yirui Zhai, Jinfeng Bai, Mei Liu, Zhouguang Hui, Ningzhi Xu	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact